Impact of Share 35 liver transplantation allocation in Australia and New Zealand

Impact of Share 35 liver transplantation allocation in Australia and New Zealand

Patients with high model for end‐stage liver disease (MELD) scores waiting for liver transplantation in Australia and New Zealand (ANZ) have had limited access to deceased donor livers and therefore binational sharing of livers, for patients with a MELD score ≥35 was introduced in February 2016. Wai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical transplantation 2024-01, Vol.38 (1), p.e15203-n/a
Hauptverfasser: Fink, Michael A., Gow, Paul J., McCaughan, Geoffrey W., Hodgkinson, Peter, Chen, John, McCall, John, Jaques, Bryon, Crawford, Michael, Strasser, Simone I., Hardikar, Winita, Brooke‐Smith, Mark, Starkey, Graham, Jeffrey, Gary P., Gane, Ed, Stormon, Michael, Evans, Helen, Tallis, Caroline, Byrne, Amanda J., Jones, Robert M.
Format: Artikel
Sprache:eng
Schlagworte:
end stage liver disease
graft survival
mortality
survival
waiting lists
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patients with high model for end‐stage liver disease (MELD) scores waiting for liver transplantation in Australia and New Zealand (ANZ) have had limited access to deceased donor livers and therefore binational sharing of livers, for patients with a MELD score ≥35 was introduced in February 2016. Waiting list mortality, post‐transplant outcomes and intention‐to‐treat survival were compared between patients whose MELD score reached 35 on the waiting list between October 2013 and April 2015 (Pre‐Share 35 group, n = 23) and patients who were Share 35 listed between February 2016 and May 2022 (Share 35 group, n = 112). There was significantly reduced waiting list mortality in share 35 listed patients in comparison to the pre‐Share 35 group (11.7% vs. 52.2%, OR .120 95% CI .044–.328, P 
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.15203